Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation

American Journal of Medicine

Volumn 128, Issue 6, 2015, Pages 654.e1-654.e10

  Hsu, Jonathan C ^a   Chan, Paul S ^b   Tang, Fengming ^b   Maddox, Thomas M ^c   Marcus, Gregory M ^d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticoagulants; Atrial fibrillation; Paroxysmal; Persistent; Stroke; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; PRASUGREL; RIVAROXABAN; TICLOPIDINE; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLACK PERSON; BODY MASS; CAUCASIAN; CHADS2 SCORE; CLINICAL PRACTICE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; EMBOLISM; ETHNICITY; FEMALE; GENDER; HEALTH INSURANCE; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; MEDICARE; OUTPATIENT; PAROXYSMAL ATRIAL FIBRILLATION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERSISTENT ATRIAL FIBRILLATION; PRESCRIPTION; PRIORITY JOURNAL; RACE; STABLE ANGINA PECTORIS; STROKE PATIENT; THROMBOEMBOLISM; TOBACCO USE; TRANSIENT ISCHEMIC ATTACK; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84930376108     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.11.035     Document Type: Article

References (28)

1. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 9 2004 1042 1046
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 18 2001 2370 2375
3. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators J Am Coll Cardiol 35 1 2000 183 187
4. S.H. Hohnloser, D. Pajitnev, and J. Pogue Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy J Am Coll Cardiol 50 22 2007 2156 2161
5. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 22 2001 2864 2870
6. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2 2010 263 272
7. C. van Walraven, R.G. Hart, and D.E. Singer Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis JAMA 288 19 2002 2441 2448
8. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 12 2007 857 867
9. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 2009 1139 1151
10. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 10 2011 883 891
11. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 7 2006 e257 e354
12. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 130 23 2014 2071 2104
13. P.S. Chan, T.M. Maddox, F. Tang, S. Spinler, and J.A. Spertus Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program) Am J Cardiol 108 8 2011 1136 1140
14. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 12 1999 927 934
15. M.R. Reynolds, J. Shah, and V. Essebag Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry Am J Cardiol 97 4 2006 538 543
16. A.M. Gallagher, S. Rietbrock, J. Plumb, and T.P. van Staa Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 6 9 2008 1500 1506
17. P.S. Chan, W.J. Oetgen, and D. Buchanan Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program J Am Coll Cardiol 56 1 2010 8 14
18. P.S. Chan, W.J. Oetgen, and J.A. Spertus The Improving Continuous Cardiac Care (IC(3)) program and outpatient quality improvement Am J Med 123 3 2010 217 219
19. F.E. Harrell Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 Springer New York
20. T.E. Raghunathan, P.W. Solenberger, and J. Van Hoewyk IVEware: Imputation and Variance Estimation Software 2002 Survey Methodology Program, Survey Research Center, Institute for Social Research, University of Michigan Ann Arbor, MI
21. S. Greenland Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies Am J Epidemiol 160 4 2004 301 305
22. G. Zou A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 7 2004 702 706
23. J.S. Healey, S.J. Connolly, and M.R. Gold Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2 2012 120 129
24. A.L. Waldo, R.C. Becker, V.F. Tapson, and K.J. Colgan Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 9 2005 1729 1736
25. R. Nieuwlaat, A. Capucci, and G.Y. Lip Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 24 2006 3018 3026
26. N.L. Glazer, S. Dublin, and N.L. Smith Newly detected atrial fibrillation and compliance with antithrombotic guidelines Arch Intern Med 167 3 2007 246 252
27. S. Connolly, J. Pogue, and R. Hart Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 9526 2006 1903 1912
28. J.B. Olesen, C. Torp-Pedersen, M.L. Hansen, and G.Y. Lip The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study Thromb Haemost 107 6 2012 1172 1179